«
‹
1
...
1123
1124
1125
1126
1127
1128
1129
1130
1131
...
5099
›
»
Page 1127 of 5099 · 254917 entries
Go to
| PDB ID | Title | official curves | Structure unit | Experimental Method |
|---|---|---|---|---|
| 2ydx | Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit | 3 | 3 | X-RAY DIFFRACTION |
| 2ydy | Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit in Orthorhombic crystal form | 1 | 1 | X-RAY DIFFRACTION |
| 2ydz | X-ray structure of the cyan fluorescent protein SCFP3A (K206A mutant) | 1 | 1 | X-RAY DIFFRACTION |
| 2ye0 | X-ray structure of the cyan fluorescent protein mTurquoise (K206A mutant) | 1 | 1 | X-RAY DIFFRACTION |
| 2ye1 | X-ray structure of the cyan fluorescent proteinmTurquoise-GL (K206A mutant) | 1 | 1 | X-RAY DIFFRACTION |
| 2ye2 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye3 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye4 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye5 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye6 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye7 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye8 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2ye9 | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yea | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yeb | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yec | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yed | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yee | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yef | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yeg | HSP90 inhibitors and drugs from fragment and virtual screening | 2 | 2 | X-RAY DIFFRACTION |
| 2yeh | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yei | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yej | HSP90 inhibitors and drugs from fragment and virtual screening | 1 | 1 | X-RAY DIFFRACTION |
| 2yek | Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET) | 2 | 2 | X-RAY DIFFRACTION |
| 2yel | Crystal Structure of the First Bromodomain of Human Brd4 with the inhibitor GW841819X | 1 | 1 | X-RAY DIFFRACTION |
| 2yem | Crystal Structure of the Second Bromodomain of Human Brd4 with the inhibitor GW841819X | 2 | 2 | X-RAY DIFFRACTION |
| 2yen | Solution structure of the skeletal muscle and neuronal voltage gated sodium channel antagonist mu-conotoxin CnIIIC | 20 | 20 | SOLUTION NMR |
| 2yeo | A39L mutation of scorpion toxin lqh-alpha-it | 1 | 1 | X-RAY DIFFRACTION |
| 2yep | STRUCTURE OF AN N-TERMINAL NUCLEOPHILE (NTN) HYDROLASE, OAT2, IN COMPLEX WITH GLUTAMATE | 4 | 4 | X-RAY DIFFRACTION |
| 2yeq | Structure of PhoD | 3 | 3 | X-RAY DIFFRACTION |
| 2yer | Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2yes | Crystal Structure of Rv0371C complex with Manganese from Mycobacterium Tuberculosis H37Rv | 2 | 2 | X-RAY DIFFRACTION |
| 2yet | Thermoascus GH61 isozyme A | 2 | 2 | X-RAY DIFFRACTION |
| 2yeu | Structural and functional insights of DR2231 protein, the MazG-like nucleoside triphosphate pyrophosphohydrolase from Deinococcus radiodurans, complex with Gd | 3 | 3 | X-RAY DIFFRACTION |
| 2yev | Structure of caa3-type cytochrome oxidase | 2 | 2 | X-RAY DIFFRACTION |
| 2yew | Modeling Barmah Forest virus structural proteins | 1 | 5 | ELECTRON MICROSCOPY |
| 2yex | Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors | 1 | 1 | X-RAY DIFFRACTION |
| 2yey | Crystal structure of the allosteric-defective chaperonin GroEL E434K mutant | 1 | 1 | X-RAY DIFFRACTION |
| 2yez | COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE | 1 | 1 | X-RAY DIFFRACTION |
| 2yf0 | Human Myotubularin related protein 6 (MTMR6) | 1 | 1 | X-RAY DIFFRACTION |
| 2yf2 | Crystal structure of the oligomerisation domain of C4b-binding protein from Gallus gallus | 1 | 1 | X-RAY DIFFRACTION |
| 2yf3 | Crystal structure of DR2231, the MazG-like protein from Deinococcus radiodurans, complex with manganese | 3 | 3 | X-RAY DIFFRACTION |
| 2yf4 | Crystal structure of DR2231, the MazG-like protein from Deinococcus radiodurans, Apo structure | 3 | 3 | X-RAY DIFFRACTION |
| 2yf9 | STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, NATIVE FORM | 1 | 1 | X-RAY DIFFRACTION |
| 2yfa | X-ray structure of McpS ligand binding domain in complex with malate | 1 | 1 | X-RAY DIFFRACTION |
| 2yfb | X-ray structure of McpS ligand binding domain in complex with succinate | 1 | 1 | X-RAY DIFFRACTION |
| 2yfc | STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH Mn and dUMP | 2 | 2 | X-RAY DIFFRACTION |
| 2yfd | STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH Mg and dUMP | 2 | 2 | X-RAY DIFFRACTION |
| 2yfe | Ligand binding domain of human PPAR gamma in complex with amorfrutin 1 | 2 | 2 | X-RAY DIFFRACTION |
| 2yfh | Structure of a Chimeric Glutamate Dehydrogenase | 1 | 1 | X-RAY DIFFRACTION |